“clinical-trial” Archives

in
Entry Author Date Location
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Inhibrx, Fresh Off $40M Funding to Advance Cancer Drugs, Eyes IPO 06/03/19 San Diego
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding 04/30/19 Texas
Clinical Analytics Platform TriNetX Raises $40M to Speed Drug Trials 03/13/19 Boston
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
Kymera Adds $65M in New Funding and Eyes First Clinical Test 11/13/18 Boston
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs 08/30/18 San Francisco
Eyeing Approval, Pfizer Touts Tafamidis Study, but Details Lacking 08/27/18 New York
Millendo Therapeutics Goes Public With OvaScience Reverse Merger 08/09/18 Detroit Ann Arbor
ResTORbio Shares Soar on Clinical Data From Lung Infection Drug 07/25/18 Boston
FDA Puts Mersana Cancer Study on Partial Hold After Patient Death 07/19/18 Boston
CTI BioPharma’s Non-Hodgkin Lymphoma Drug Fails Study, Shares Sink 07/09/18 Seattle
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion 07/05/18 Boston
Teva’s Migraine Drug Fails in Phase 3 for Chronic Cluster Headaches 06/15/18 National
Aravive Seeks Nasdaq Perch Via Reverse Merger With Biotech Versartis 06/04/18 Texas
Evelo IPO Raises $85M for Microbiome Drugs in Inflammation, Cancer 05/09/18 Boston
Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer 05/09/18 Texas
Will New Study Cut Guesswork for Depression Medicine Prescriptions? 05/07/18 National
Virta Health Hauls in $45M to Expand “Diabetes-Reversing” Software 04/04/18 San Francisco
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More 03/30/18 National
Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies 03/29/18 Boston
Bio Roundup: Trump Health, Cholesterol Wars, 23andMe OK & More 03/09/18 National
Bluegrass Vascular Opens U.S. Clinical Trial for Obstructed Veins 01/18/18 Texas
Clinical Trial Lab Intrinsic Imaging Joins Rise of AI in Radiology 10/20/17 Texas
Experimental Drug With San Antonio Roots Changes Home After Merger 08/08/17 Texas
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More 06/23/17 National
Cook Medical Gets FDA OK for Device to Treat Rare Birth Defect 05/22/17 Indiana
Page 2 of 5 « previous page · next page »